Who is the CEO of Hamps Bio Limited?
- Answer Field
-
Herrik Shah serves as the CEO of Hamps Bio Limited, driving the company’s strategic growth and operations.
BAJAJ BROKING
Hamps Bio Limited, incorporated in 2007, specializes in marketing and distributing pharmaceutical and FMCG products. Its pharmaceutical segment, branded as "Hamps," includes syrups, capsules, injectables, and powders. The FMCG division, "FzyEzy," focuses on freeze-dried and frozen items like mango and beet powders. With a wide product range, the company caters to B2B and B2C markets across India and internationally. Its robust distribution network includes 50 distributors and prominent e-commerce platforms like Amazon and Flipkart.
The company's diverse portfolio and expanding global reach strengthen its market position.
Interested? Learn more about the Hamps Bio IPO.
Details | Information |
IPO Date | December 13–17, 2024 |
Price | ₹51 per share |
Lot Size | 2,000 shares |
Total Issue Size | ₹6.22 Cr (12.2 lakh shares) |
Issue Type | Fixed Price IPO |
Listing Exchange | BSE SME |
Pre-issue Shareholding | 3,136,000 |
Post-issue Shareholding | 4,356,000 |
Purpose of the IPO
Event | Date |
IPO Opens | December 13, 2024 |
IPO Closes | December 17, 2024 |
Allotment Finalization | December 18, 2024 |
Refunds Initiation | December 19, 2024 |
Listing Date | December 20, 2024 |
Price Band for the IPO
Minimum Lot Size and Application Details
Online Application Process
Key Financial Metrics
Recent Performance and Growth Prospects
Potential Risks of Investing in the IPO
Opportunities and Growth Potential
Metric | Value |
ROE | 21.14% |
ROCE | 18.31% |
Debt/Equity | 0.31 |
PAT Margin | 7.73% |
Role | Details |
Registrar | Bigshare Services Pvt Ltd |
Lead Manager | Marwadi Chandarana Intermediaries |
Market Maker | Pure Broking |
Address: 2900/112, GIDC, Near Atul Limited, Ankleshwar, Bharuch 393 002
Phone: +91 8000006663
Email: info@hampsbio.com
Website: www.hampsbio.com
Hamps Bio Limited offers an entry into pharmaceutical and FMCG segments with its upcoming IPO. The company’s strong financials and diverse product range highlight its growth potential. However, investors should weigh valuation risks carefully.
Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Hamps Bio IPO.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Herrik Shah serves as the CEO of Hamps Bio Limited, driving the company’s strategic growth and operations.
The Hamps Bio IPO will open for subscription on December 13, 2024, and close on December 17, 2024.
Hamps Bio Limited specializes in pharmaceuticals and freeze-dried FMCG products. Its diversified portfolio and global market reach make the business model sustainable.
The issue size is ₹6.22 crores, comprising a fresh issue of 12.2 lakh shares.
'Pre-apply' allows investors to place bids for the Hamps Bio IPO before the subscription officially opens, streamlining the application process.
You will receive confirmation after successful payment and approval of the UPI mandate request.
The minimum lot size is 2,000 shares, requiring an investment of ₹102,000 for retail investors.
What is the allotment date for the Hamps Bio IPO?
Bigshare Services Pvt Ltd is the official registrar for the Hamps Bio IPO, ensuring smooth allotment and refund processes.
No governance issues or red flags have been reported; the leadership team brings extensive experience and credibility to the company.
No Result Found
Disclaimer :
The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.
The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.
Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.
BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.
Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For more disclaimer, check here : https://www.bajajbroking.in/disclaimer
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading